Literature DB >> 7877149

Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.

A Kapurniotu1, J W Taylor.   

Abstract

The conformational and pharmacological effects of the introduction of conformational constraints in the form of i-(i + 4) lactam-bridges in the potential amphiphilic alpha-helical region (8-21) of human calcitonin (hCT) were studied. The following three cyclic hCT analogues were synthesized: cyclo17,21-[Lys17,Asp21]hCT (1), cyclo17,21- [Asp17,Lys21]hCT (2) and cyclo10,14-[Lys10,-Asp14]hCT (3). For their syntheses, solid-phase methodology was used in combination with either direct side chain to side chain cyclization on the solid support or a segment-condensation strategy. Circular dichroism studies in aqueous buffer, pH 7.0, indicated that the conformational effects were different for each lactam bridge introduced. Significant induction of alpha-helical structure was observed only for peptide 3. In contrast, peptide 1 and hCT had similar CD spectra, indicative of mixed disordered and beta-sheet conformations, and peptide 2 had a weaker spectrum consistent with the formation of a more ordered but nonhelical structure. In rat brain receptor binding assays, peptide 2 showed a nearly 80-fold higher potency than hCT or peptides 1 and 3. All three analogues stimulated adenylyl cyclase in the rat kidney membrane at 5-fold lower concentrations than hCT and with similar maximal effects. In vivo hypocalcemic assays, performed in mice by analysis of serum calcium levels 1 h after sc injection, indicated that peptide 2 had similar maximal effects to hCT and was 10-20 times more potent than hCT at doses giving half-maximal effects. In contrast, peptides 1 and 3 were not significantly more potent than hCT. Our findings indicate compatibility of all three lactam bridges and, most probably, also the amphiphilic alpha-helix, with the pharmacological activities of hCT. However, the properties of peptide 2 also suggest that another conformation, possibly a type I beta-turn involving residues 17-20, may play an important role. A multistep mechanism of receptor recognition by hCT that might account for these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877149     DOI: 10.1021/jm00005a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Calcitonin and bone formation: a knockout full of surprises.

Authors:  Mone Zaidi; Baljit S Moonga; Etsuko Abe
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Short constrained peptides that inhibit HIV-1 entry.

Authors:  Samuel K Sia; Peter A Carr; Andrea G Cochran; Vladimir N Malashkevich; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

3.  Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist.

Authors:  Maoqing Dong; Jerez A Te; Xiequn Xu; Jinhui Wang; Delia I Pinon; Laura Storjohann; Andrew J Bordner; Laurence J Miller
Journal:  Biochemistry       Date:  2011-08-30       Impact factor: 3.162

Review 4.  The Charcot foot as a complication of diabetic neuropathy.

Authors:  Janice V Mascarenhas; Edward B Jude
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

5.  Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis.

Authors:  Max D Kauther; Hagen S Bachmann; Laura Neuerburg; Martina Broecker-Preuss; Gero Hilken; Florian Grabellus; Gabriele Koehler; Marius von Knoch; Christian Wedemeyer
Journal:  BMC Musculoskelet Disord       Date:  2011-08-15       Impact factor: 2.362

6.  Acetyl-[Asn30,Tyr32]-calcitonin fragment 8-32 forms channels in phospholipid planar lipid membranes.

Authors:  Daniela Meleleo; Enrico Gallucci; Vittorio Picciarelli; Silvia Micelli
Journal:  Eur Biophys J       Date:  2007-03-29       Impact factor: 2.095

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.